Facts Matter for Patients with Cancer During the COVID-19 Pandemic, Says One Advocate

Video

There's a lot of rapidly changing information on COVID-19 and patients need to take their time and find the facts that matter.

While patients with cancer continue to feel the effects of the COVID-19 pandemic, it is critical to seek out scientific facts and avoid the misinformation and noise that comes with a rapidly evolving news landscape, says Raymond Foundation co-founder Martha Raymond.

CURE® recently spoke with Raymond about how patients and their caregivers are feeling the pressure of navigating the global pandemic while also maintaining their sanity. When asked what advice she would give this population as they try to make sense of things, she stressed the importance of evidence-based information and a clear channel of communication with one’s care team.

Transcription:

That’s a difficult question, for sure. I think for all of us, (we should) really listen to the healthcare professionals. Don’t let the noise of the media outlets and television drown out the evidence-based science that we all need to focus on.

I think that cancer patients, caregivers, survivors, they are really smart about knowing how to navigate information and learning what is accurate and what is not, what is evidence-based and what is factual, and really, what is current. So much fo the information you learn is just not current. And I think that cancer patients are really good at delving into all of that, so that’s one thing I would say is to listen to your healthcare professionals.

And if you have any questions, I know several patients we’ve spoken with feel like they might have had the coronavirus or are experiencing symptoms, and I think to really take advantage of now, telemedicine more than ever is so important. Being able to have that relationship with your physician or primary care, just to be able to say hey, I’m not feeling 100% right now, and to listen to their guidance as opposed to other information that maybe isn’t as based in science.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.